Alpha Tau Medical (DRTS) Shares Outstanding (Diluted Average) (2020 - 2025)

Alpha Tau Medical has disclosed Shares Outstanding (Diluted Average) across 6 years of filings, most recently posting $80.6 million for Q4 2025.

• Shares Outstanding (Diluted Average) for Q4 2025 came in at $80.6 million, up 15.24% year-over-year; the trailing twelve-month figure through Dec 2025 was $80.6 million (up 15.24% YoY), and the FY2025 annual result was $80.6 million, up 15.24% from the prior year.
• Shares Outstanding (Diluted Average) came in at $80.6 million for Q4 2025 at Alpha Tau Medical, up from $250.0 in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $80.6 million in Q4 2025 to a low of $220.0 in Q2 2024.
• The 5-year median for Shares Outstanding (Diluted Average) is $63.5 million (2022), against an average of $46.3 million.
• Across the five-year window, Shares Outstanding (Diluted Average) advanced 0.64% in 2021 and jumped 56.74% in 2022, its largest moves.
• Alpha Tau Medical's Shares Outstanding (Diluted Average) stood at $40.5 million in 2021, then surged by 56.74% to $63.5 million in 2022, then gained by 9.2% to $69.4 million in 2023, then climbed by 0.79% to $69.9 million in 2024, then rose by 15.24% to $80.6 million in 2025.
• The last three Shares Outstanding (Diluted Average) figures came in at $80.6 million (Q4 2025), $250.0 (Q2 2025), and $69.9 million (Q4 2024), per Business Quant data.